MicroRNAs as Potential Biomarkers for Alzheimer’s Disease in Women
Open Access
Abstract
Alzheimer’s disease (AD) affects approximately 50 million people worldwide, with women comprising two-thirds of those affected. Despite this disproportionate impact, the sex-specific pathological mechanisms underlying AD in women remain poorly understood, and female-specific biomarkers have been significantly understudied. This critical knowledge gap requires focused research to improve diagnostic and therapeutic approaches for women with AD. In this review, we systematically examine the pathological mechanisms underlying AD in women, including sex-related differences in inflammation, autophagy, and metabolic dysfunction. We further explore microRNA (miRNA) expression patterns and evaluate miRNA candidates as potential biomarkers for AD in women based on current literature. Through this analysis, we identified approximately 20 miRNA candidates derived from diverse human samples, including brain tissue, blood, and cerebrospinal fluid, in multiple independent studies. These candidates demonstrate the potential for developing accessible, non-invasive biomarkers, particularly those identified in blood and cerebrospinal fluid. However, the limited overlap between studies highlights that female-specific miRNA biomarker research for AD remains in its early discovery phase, emphasizing the urgent need for large-scale validation studies and standardized methodological approaches to advance this promising field for clinical application.Keywords
This publication has 66 references indexed in Scilit:
- Sex‐ and region‐dependent neuroinflammation in Alzheimer's diseaseAlzheimer's & Dementia, 2025
- Preclinical Alzheimer's disease shows alterations in circulating neuronal‐derived extracellular vesicle microRNAs in a multiethnic cohortAlzheimer's & Dementia, 2025
- Effects of brain microRNAs in cognitive trajectory and Alzheimer’s diseaseActa Neuropathologica, 2024
- Characterizing molecular and synaptic signatures in mouse models of late‐onset Alzheimer's disease independent of amyloid and tau pathologyAlzheimer's & Dementia, 2024
- Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060)Alzheimer's & Dementia, 2021
- Women's higher brain metabolic rate compensates for early Alzheimer's pathologyAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020
- Clinical utility of FDG-PET for the clinical diagnosis in MCIEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Alteration of the microRNA network during the progression of Alzheimer's diseaseEMBO Molecular Medicine, 2013
- X-chromosome-encoded microRNA-19 and -18 are possible modulators of female immunityBioEssays, 2013
- Conjugated Equine Estrogens and Global Cognitive Function in Postmenopausal WomenWomen's Health Initiative Memory StudyJAMA, 2004